We are pleased to announce an MoU with JSS Medical College and Academy of Higher Education and Research, Mysuru to work together in the areas of hemoglobinopathies and rare diseases. The aim is to work on collaborative projects to develop affordable and efficient diagnostics, therapeutics, and treatment options.
Related Posts
COVID-19 in endemic stage, still need to monitor viral load, new variant: Top expert
Coronavirus is in the endemic stage but the viral load and emergence... read more
Press Release: Researchers Unveil Detailed Genome of Malaria Mosquito Vector
New ‘gold standard’ reference genome reveals thousands of new genes vital for... read more
MoU Signing with Gujrat Biotechnology Research Centre
TIGS and Gujarat Biotechnology Research Centre (GBRC), Department of Science and Technology, Government... read more
The gene whispers
TIGS got featured in a newsroom article on the Tata group website.... read more
TIGS and the Avestagenome Project® partner to advance research in Rare Genetic Disorders
The Avestagenome Project® International Pvt. Ltd. (AGENOME) & Avesthagen Limited, in partnership... read more
Monkeypox Scare Gets Real In India: Are We Prepared? | Left, Right & Centre Interview with NDTV
All about Monkeypox, What, Why and How? Watch Dr. Rakesh Mishra, Director TIGS,... read more
Why environmental surveillance for avian influenza is vital
Wastewater-based epidemiology or pathogen surveillance has become an integral component of environmental surveillance... read more
Visit by Dr. Arvind Virmani
We were glad to host Dr. Arvind Virmani , Member, NITI Aayog... read more
Anti-microbial resistance – The next pandemic
“Although the link between human anti-microbial use and emergence of resistance is... read more

